Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Surgical treatment of elderly patients with endometrial cancer (≥ 65 years).

De Marzi P, Ottolina J, Mangili G, Rabaiotti E, Ferrari D, Viganò R, Candiani M.

J Geriatr Oncol. 2013 Oct;4(4):368-73. doi: 10.1016/j.jgo.2013.07.001. Epub 2013 Aug 1.

PMID:
24472481
2.

A comparison of perioperative morbidity, perioperative mortality, and disease-specific survival in elderly women (>or=70 years) versus younger women (<70 years) with endometrioid endometrial cancer.

Vaknin Z, Ben-Ami I, Schneider D, Pansky M, Halperin R.

Int J Gynecol Cancer. 2009 Jul;19(5):879-83. doi: 10.1111/IGC.0b013e3181a73a12.

PMID:
19574777
3.

[Clinical application of adult comorbidity evaluation-27 in endometrial cancer].

Tian WY, Wang YM, Yan Y, Gao JP, Sun DD, Jiang S, Sheng Y, Teng F, Xue FX.

Zhonghua Fu Chan Ke Za Zhi. 2016 Nov 25;51(11):810-817. doi: 10.3760/cma.j.issn.0529-567X.2016.11.003. Chinese.

PMID:
27916063
4.

[The impact of therapeutic management on survival of elderly women with endometrial cancer].

Ouldamer L, Duquesne M, Arbion F, Barillot I, Marret H, Body G.

Gynecol Obstet Fertil. 2012 Dec;40(12):759-64. doi: 10.1016/j.gyobfe.2012.07.015. Epub 2012 Sep 18. French.

PMID:
22995058
5.

Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?

Bassarak N, Blankenstein T, Brüning A, Dian D, Bergauer F, Friese K, Mylonas I.

BMC Cancer. 2010 May 21;10:224. doi: 10.1186/1471-2407-10-224.

6.

An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.

Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR.

Anticancer Res. 2000 May-Jun;20(3B):1977-84.

PMID:
10928137
7.

The impact of obesity on the 30-day morbidity and mortality after surgery for endometrial cancer.

Mahdi H, Jernigan AM, Aljebori Q, Lockhart D, Moslemi-Kebria M.

J Minim Invasive Gynecol. 2015 Jan;22(1):94-102. doi: 10.1016/j.jmig.2014.07.014. Epub 2014 Jul 24.

PMID:
25064420
8.

Endometrioid adenocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy.

Chee JJ, Ho TH, Tay EH, Low JJ, Yam KL.

Ann Acad Med Singapore. 2003 Sep;32(5):670-5.

PMID:
14626800
9.
10.

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, McKee B, Hoskins WJ, Barakat RR.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):79-85.

PMID:
12182977
11.

[Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].

Wang ZQ, Zhang Y, Wang JL, Shen DH, Mu T, Zhao X, Yao YY, Bai Y, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Jan;47(1):33-9. Chinese.

PMID:
22455691
12.

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.

Papanikolaou A, Kalogiannidis I, Goutzioulis M, Misailidou D, Makedos A, Vergote I, Makedos G.

Arch Gynecol Obstet. 2006 May;274(2):91-6. Epub 2006 Mar 4.

PMID:
16518607
13.

Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.

Panggid K, Cheewakriangkrai C, Khunamornpong S, Siriaunkgul S.

J Obstet Gynaecol Res. 2010 Oct;36(5):1044-8.

PMID:
21058438
14.

Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study.

Coronado PJ, Fasero M, Baquedano L, Martinez-Maestre MA, Casado A, Vidart JA, Herraiz MA.

Int J Gynecol Cancer. 2014 May;24(4):703-12. doi: 10.1097/IGC.0000000000000120.

PMID:
24651627
15.

Recurrence and survival in surgically treated endometrioid endometrial cancer.

Sanjuán A, Cobo T, Escaramís G, Rovirosa A, Ordi J, García S, Hernández S, Caparrós X, Torné A, Martínez Román S, Lejárcegui JA, Pahisa J.

Clin Transl Oncol. 2008 Aug;10(8):505-11.

PMID:
18667382
16.

Location of disease in patients who die from endometrial cancer: a study of 414 patients from a single institution.

Barlin JN, Wysham WZ, Ferda AM, Khoury-Collado F, Cassella DK, Alektiar KM, Hensley ML, Chi DS, Barakat RR, Abu-Rustum NR.

Int J Gynecol Cancer. 2012 Nov;22(9):1527-31. doi: 10.1097/IGC.0b013e31827057e8.

PMID:
23051960
17.

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C.

J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16. doi: 10.1093/jnci/djn397. Epub 2008 Nov 25.

PMID:
19033573
18.

Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.

Alektiar KM, McKee A, Venkatraman E, McKee B, Zelefsky MJ, Mychalczak BR, Hoskins WJ, Barakat RR.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):707-13.

PMID:
12062616
19.

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.

Alektiar KM, Venkatraman E, Chi DS, Barakat RR.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):111-7.

PMID:
15850910
20.

Impact of age on 30-day mortality and morbidity in patients undergoing surgery for endometrial cancer.

Mahdi H, Lockhart D, Maurer KA.

Gynecol Oncol. 2015 Apr;137(1):106-11. doi: 10.1016/j.ygyno.2015.01.543. Epub 2015 Jan 29.

PMID:
25640765

Supplemental Content

Support Center